Supporting PharmD graduates after unsuccessful licensing examination attempts

IF 1.3 Q3 EDUCATION, SCIENTIFIC DISCIPLINES
Paul Fina , Daniel Kerner , Edward Ofori , Darilyn McClain , Jeremy Hughes
{"title":"Supporting PharmD graduates after unsuccessful licensing examination attempts","authors":"Paul Fina ,&nbsp;Daniel Kerner ,&nbsp;Edward Ofori ,&nbsp;Darilyn McClain ,&nbsp;Jeremy Hughes","doi":"10.1016/j.cptl.2025.102327","DOIUrl":null,"url":null,"abstract":"<div><div>Not passing the North American Pharmacy Licensure Examination (NAPLEX) is the reality for a significant number of PharmD graduates. The average first time pass rates for the NAPLEX have experienced significant drops since 2017, hitting an all-time low (76.6 %) for the Class of 2023. While most candidates eventually pass the NAPLEX, a staggering 3228 PharmD graduates remain unlicensed due to unsuccessful licensure examinations from cycle years 2022 to 2024. Further decline is anticipated with impending changes to the structure of the NAPLEX in 2025. Unfortunately, unlicensed graduates are unable to practice and earn pharmacist salaries, leaving them with significant student debt. This commentary, examines the key drivers of this problem and suggests pragmatic measures to support the success of graduates who have not yet passed NAPLEX.</div></div>","PeriodicalId":47501,"journal":{"name":"Currents in Pharmacy Teaching and Learning","volume":"17 6","pages":"Article 102327"},"PeriodicalIF":1.3000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Currents in Pharmacy Teaching and Learning","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877129725000486","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"EDUCATION, SCIENTIFIC DISCIPLINES","Score":null,"Total":0}
引用次数: 0

Abstract

Not passing the North American Pharmacy Licensure Examination (NAPLEX) is the reality for a significant number of PharmD graduates. The average first time pass rates for the NAPLEX have experienced significant drops since 2017, hitting an all-time low (76.6 %) for the Class of 2023. While most candidates eventually pass the NAPLEX, a staggering 3228 PharmD graduates remain unlicensed due to unsuccessful licensure examinations from cycle years 2022 to 2024. Further decline is anticipated with impending changes to the structure of the NAPLEX in 2025. Unfortunately, unlicensed graduates are unable to practice and earn pharmacist salaries, leaving them with significant student debt. This commentary, examines the key drivers of this problem and suggests pragmatic measures to support the success of graduates who have not yet passed NAPLEX.
求助全文
约1分钟内获得全文 求助全文
来源期刊
Currents in Pharmacy Teaching and Learning
Currents in Pharmacy Teaching and Learning EDUCATION, SCIENTIFIC DISCIPLINES-
CiteScore
2.10
自引率
16.70%
发文量
192
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信